Dicerna Pharmaceuticals
DRNA
#3960
Rank
NZ$5.15 B
Marketcap
NZ$66.22
Share price
0.00%
Change (1 day)
16,910.33%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: NZ$5.15 Billion

As of December 2025 Dicerna Pharmaceuticals has a market cap of NZ$5.15 Billion. This makes Dicerna Pharmaceuticals the world's 3960th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$4.69 B7.58%
2021NZ$4.35 B88.48%
2020NZ$2.31 B-1.2%
2019NZ$2.34 B115.37%
2018NZ$1.08 B65.56%
2017NZ$0.65 B660.98%
2016NZ$86.28 M-75.84%
2015NZ$0.35 B-4.47%
2014NZ$0.37 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
NZ$0.97 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$16.32 B 216.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$248.13 B 4,709.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$91.60 B 1,675.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$437.45 B 8,379.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.41 B 5,820.26%๐Ÿ‡บ๐Ÿ‡ธ USA